Here are 14 key notes on orthopedic and spine device companies over the past week.
Amedica named Giuseppe Pezzotti, PhD, to its scientific advisory board.
Amedica signed a definitive agreement with institutional investors to raise up to $15 million in a concurrent registered direct offering of common stock and Series B warrants and private placement of Series A warrants and Series C warrants.
The Institute for Applied Neurosciences, a nonprofit within the Medical University of South Carolina in Charleston, licensed a minimally invasive spine surgery implant to Amendia.
Blue Belt Technologies announced commercial support for Smith & Nephew's ZUK unicompartmental knee implant.
ChoiceSpine received a CE Mark for the VEO Lateral Interbody Fusion System.
Exactech hosted more than 70 shoulder specialists at its recent Shoulder Masters Course in San Francisco.
Raphael Roybal, MD, of Memorial University Medical Center in Savannah, Ga., is the first surgeon in the Low Country to use Expanding Orthopedics' FLXfit.
Zacks upgraded Integra LifeSciences, a health technology company, from a "sell" rating to a "hold" rating.
Mount Sinai is a new clinical site for InVivo Therapeutics' Neuro-Spinal Scaffold trial for patients with spinal cord injury.
InVivo Therapeutics also enrolled the fifth patient in its investigational Neuro-Spinal Scaffold clinical trial.
The Dow Jones Sustainability North America Index named Dublin-based Medtronic Plc among the world's leading companies for sustainability.
The U.S. Patent and Trademark Office has awarded Nextremity Solutions with seven patents.
Orchid Orthopaedic Solutions acquired Alhenia AG, a coated orthopedic implant device company.
The first Navio system-assisted partial knee replacement performed using Smith & Nephew's ZUK unicompartmental knee has been successfully completed.